The clinical research industry has grown to be an integral part of the bigger pharmaceutical industry today. It helps pharma companies conduct research faster and in much more productive ways. In today’s drug development cost of 2.6 billion per new molecule, clinical trials hold about 70% share, which means that any changes in this industry […]
Read More →
Outsourcing in the clinical trial industry has been on the rise for the last several decades. This has been due to a combination of several factors, including the increasing cost of research, blockbuster molecules going off-patent causing revenue loss, and lack of extensive in-house R&D infrastructure. This has resulted in an interesting situation, where increasingly […]
Read More →
Trial managers worldwide have been focusing on specific regions for placing their clinical trials. So much so that about 60-70% of clinical trials globally are conducted in the USA and Europe alone. However, this is slated to change or should change, if one consults a recent white paper published by Frost & Sullivan. The white […]
Read More →
Taiwan offers a supportive and efficient regulatory landscape for clinical trials, primarily managed by the Taiwan Food and Drug Administration (TFDA). The TFDA simplifies the approval process and provides expedited reviews for innovative therapies, allowing studies to start more quickly. With its advanced healthcare facilities and diverse patient population, Taiwan has become an attractive destination […]
Read More →
Recently, the Thailand FDA has brought a revised list of Institutional Review Boards (IRBs)/Ethics Committees (ECs) that it recognizes for acceptance of clinical trial applications. In our previous articles (see Part I and Part II), we’ve discussed the regulatory scenario in Thailand, including We’ve also presented a list of ethics committees that are recognized for application to the […]
Read More →
Taiwan presents excellent opportunities for clinical trials, featuring advanced healthcare facilities, a diverse patient population, and strong recruitment rates, particularly for diseases like hepatitis B and diabetes. The regulatory environment, governed by the Taiwan Food and Drug Administration (TFDA), is efficient and supportive, offering expedited reviews for innovative therapies. This combination of opportunities and a […]
Read More →
Investigators, from Brazil who were specialized in Allergy and Immunology segment, were invited to participate in feasibility of a new phase II clinical trial. What’s was the trial about? It’s a phase II – dose selection and confirmatory – clinical trial planned to be conducted in Brazil. What kind of patients were required for this clinical trial? […]
Read More →
With patients with ovarian cancer as the target trial population, clinical trial feasibility was performed. The clinical trial sites/investigators, who participated in this feasibility came mainly from India, Russia, the Philippines, Vietnam, Thailand, and South Korea. What are the causes of ovarian cancer? The causes of ovarian cancer are unclear but doctors have identified factors that […]
Read More →
Worldwide, breast cancer is the most common invasive cancer in women. Along with lung cancer, breast cancer is the most commonly diagnosed cancer, with 2.09 million cases each in 2018, and Breast cancer affects 1 in 7 (14%) of women worldwide. What is breast cancer? Breast cancer is a cancer that develops from breast tissue. […]
Read More →
Complex regional pain syndrome (CRPS) also known as reflex sympathetic dystrophy (RSD) is a form of chronic pain that usually affects an arm or a leg. CRPS typically develops after an injury, surgery, a stroke, or a heart attack. However, the cause of CRPS is not completely understood. People with CRPS have changing combinations of […]
Read More →